Tubular Necrosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-02-18
Clinical Trial Update: Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF) [Phase 2, Phase 3]
Phase 2/3 clinical trial update for QRX3 in acute kidney injury due to acute tubular necrosis in hospitalized patients; the study is current…
CLINICAL_TRIALS trial_result · 2025-05-15
Clinical Trial Update: NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients [Phase 2, Phase 3]
NEPH-ROSIS, a Phase 2/3 pilot trial for treating acute kidney injury in hospitalized cirrhosis patients, has been terminated.
CLINICAL_TRIALS research · 2015-09-30
Clinical Trial Update: Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant. [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating bone marrow-derived mesenchymal stem cells (BM-MSCs) to improve early graft function after donation af…
CLINICAL_TRIALS research · 2015-09-28
Clinical Trial Update: Effect of BM-MSCs in DCD Kidney Transplantation [Phase 1, Phase 2]
A clinical trial update on the use of bone marrow-derived mesenchymal stem cells (BM-MSCs) in donation-after-cardiac-death kidney transplant…
CLINICAL_TRIALS trial_result · 2014-08-06
Clinical Trial Update: Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery [Phase 1]
A Phase 1 study evaluating allogeneic multipotent stromal cells for acute kidney injury after cardiac surgery has been completed.
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.